-
- Kurokawa Syunya
- Department of Psychiatry, Keio University School of Medicine
-
- Kishimoto Taishirou
- Department of Psychiatry, Keio University School of Medicine
-
- Sanada Kenji
- Department of Psychiatry, Showa University School of Medicine
-
- Mimura Masaru
- Department of Psychiatry, Keio University School of Medicine
Bibliographic Information
- Other Title
-
- 腸内細菌と自閉症スペクトラム障害
- チョウ ナイ サイキン ト ジヘイショウ スペクトラム ショウガイ
Search this article
Description
Interest in the microbiota‐gut‐brain axis, in which the intestine and the brain interact with each other via the microbiome and its metabolites, is rapidly growing. Autism spectrum disorder (ASD) is one of the most reported microbiota‐related disorders in the neuropsychiatric field. In ASD, differences in specific bacterial species and/or diversity (dysbiosis) as compared to healthy controls have been previously reported. Fecal Microbiota Transplantation (FMT) , for the purpose of restoring dysbiosis, has been noted as a novel treatment option for ASD. In this paper, we introduce up‐to‐date observational and intervention studies regarding the microbiota‐gut‐brain axis, and discuss future prospects, such as the possibility of therapeutic application and understanding the pathology of ASD through microbiome studies. There are no potential conflicts of interest to disclose.
Journal
-
- Japanese Journal of Biological Psychiatry
-
Japanese Journal of Biological Psychiatry 30 (2), 55-59, 2019
Japanese Society of Biological Psychiatry
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390846609789356288
-
- NII Article ID
- 130007777419
-
- NII Book ID
- AA12468060
-
- ISSN
- 21866465
- 21866619
-
- NDL BIB ID
- 029911876
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- CiNii Articles
-
- Abstract License Flag
- Disallowed